Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Recommendation of “Moderate Buy” by Analysts

Axon Enterprise, Inc. (NASDAQ:AXON) has earned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $427.83.

Several brokerages recently commented on AXON. Craig Hallum upped their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Robert W. Baird raised their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the transaction, the director now owns 7,379 shares of the company’s stock, valued at approximately $2,752,588.37. The trade was a 5.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 411,006 shares of company stock valued at $161,360,618. 6.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of AXON. Blue Trust Inc. boosted its position in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Quent Capital LLC raised its stake in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC boosted its position in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the period. Brooklyn Investment Group bought a new position in shares of Axon Enterprise in the third quarter worth $41,000. Finally, Asset Dedication LLC acquired a new position in shares of Axon Enterprise during the second quarter valued at $47,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $599.35 on Monday. Axon Enterprise has a 52 week low of $220.78 and a 52 week high of $624.84. The business has a fifty day simple moving average of $438.79 and a 200-day simple moving average of $357.90. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $45.70 billion, a P/E ratio of 154.87, a P/E/G ratio of 15.05 and a beta of 0.94.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.